Comment on

• a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

  Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK, Kirn DH. Khuri FR, et al. Nat Med. 2000 Aug;6(8):879-85. doi: 10.1038/78638. Nat Med. 2000. PMID: 10932224 Clinical Trial.